Skip to main content
Equibles

Invesco Ltd.

Position in RVMD — Revolution Medicines, Inc.

CIK 914208 Atlanta, GA
Back to RVMD Full portfolio

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$108,301,586
+$70,097,509 QoQ
Shares Held
578,287
+47.2% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. RVMD ranks #23 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in RVMD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $108,301,586 578,287
2026-03-31 $38,204,077 392,844
2025-12-31 $29,299,330 367,851
2025-09-30 $9,383,990 200,942
2025-06-30 $8,352,027 227,019
2025-03-31 $6,727,556 190,259
2024-12-31 $5,146,096 117,652
2024-09-30 $6,677,604 147,246
2024-06-30 $3,824,763 98,551
2024-03-31 $3,043,509 94,431
2023-12-31 $3,694,499 128,818
2023-09-30 $5,685,525 205,402
2023-06-30 $1,895,664 70,866
2023-03-31 $1,310,818 60,518
2022-12-31 $633,444 26,593
2022-09-30 $530,900 26,922
2022-06-30 $449,925 23,085
2022-03-31 $585,173 22,939
2021-12-31 $572,188 22,733
2021-09-30 $543,293 19,749
2021-06-30 $749,762 23,622
2021-03-31 $415,397 9,054
2020-12-31 $679,086 17,153
2020-06-30 $520,430 16,485